Oct 31, 2016 9:00 am EDT Capricor Therapeutics Presents Positive 12-Month Results from DYNAMIC at TCT 2016
Oct 20, 2016 7:00 am EDT Capricor Therapeutics Awarded Up to $4.2 Million from National Institutes of Health to Evaluate Exosomes for Hypoplastic Left Heart Syndrome
Oct 05, 2016 7:00 am EDT Capricor Therapeutics Completes Enrollment in Phase II ALLSTAR Clinical Trial
Sep 26, 2016 7:00 am EDT Capricor Therapeutics Awarded $2.4 Million from U.S. Department of Defense to Support Manufacturing Process Development for Therapeutic Exosomes
Sep 21, 2016 11:00 am EDT Capricor Therapeutics Announces Closing of Public Offerings Raising Approximately $10.0 Million in Net Proceeds
Sep 07, 2016 6:00 am EDT Capricor Therapeutics Completes Enrollment in Randomized HOPE Clinical Trial in Duchenne Muscular Dystrophy
Sep 01, 2016 7:00 am EDT Capricor Therapeutics to Present at the NewsMakers in the Biotech Industry Conference